EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mutation spectra of the BRCA1 / 2 genes in human breast and ovarian cancer and germline

Yumiko Koi, Arisa Watanabe, Akari Kawasaki, Satomi Ideo, Nao Matsutani, Kaname Miyashita, Seijiro Shioi, Eriko Tokunaga, Mototsugu Shimokawa, Yoshimichi Nakatsu, Isao Kuraoka, Shinya Oda iD

Environmental and Molecular Mutagenesis · 2024

DOI: 10.1002/em.22614 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental and Molecular Mutagenesis, 2024. Verfasst von Yumiko Koi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Oncology, NHO Kyushu Cancer Center, Fukuoka, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, Germ-Line Mutation, Ovarian Neoplasms. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Annotating genomic sequence alterations is sometimes a difficult decision, particularly in missense variants with uncertain pathogenic significance and also in those presumed as germline pathogenic variants. We here suggest that mutation spectrum may also be useful for judging them. From the public databases, 982 BRCA1 /1861 BRCA2 germline missense variants and 294 BRCA1 /420 BRCA2 somatic missense variants were obtained. We then compared their mutation spectra, i.e., the frequencies of two transition‐ and four transversion‐type mutations, in each category. Intriguingly, in BRCA1 variants, A:T to C:G transversion, which was relatively frequent in the germline, was extremely rare in somatic, particularly breast cancer, cells ( p = .03). Conversely, A:T to T:A transversion was most infrequent in the germline, but not rare in somatic cells. Thus, BRCA1 variants with A:T to T:A transversion may be suspected as somatic, and those with A:T to C:G as being in the germline. These tendencies of mutation spectrum may also suggest the biological and chemical origins of the base alterations. On the other hand, unfortunately, variants of uncertain significance (VUS) were not distinguishable by mutation spectrum. Our findings warrant further and more detailed studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsGerm-Line MutationOvarian NeoplasmsHumansFemaleBRCA1 ProteinBRCA2 ProteinMutation, MissenseGenes, BRCA1Genes, BRCA2

Stichwörter der Autor:innen

BRCA1/2germline variantshereditary breast and ovarian cancer (HBOC)mutation spectrumsomatic variants

Substanzen

BRCA1 ProteinBRCA2 ProteinBRCA1 protein, humanBRCA2 protein, human

Autor:innen und Institutionen

  • Department of Breast Oncology, NHO Kyushu Cancer Center, Fukuoka, Japan.
  • Department of Chemistry, Faculty of Science, Fukuoka University, Fukuoka, Japan.
  • Cancer Genetics Laboratory, Clinical Research Institute, NHO Kyushu Cancer Center, Fukuoka, Japan.
  • Cancer Genetics and Genomics, NHO Kyushu Cancer Center, Fukuoka, Japan.
  • Department of Biostatistics, Yamaguchi University Graduate School of Medicine, Ube, Japan.

ORCID-Profile: Shinya Oda

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Koi, Y., Watanabe, A., Kawasaki, A., Ideo, S., Matsutani, N., Miyashita, K., Shioi, S., Tokunaga, E., Shimokawa, M., Nakatsu, Y., Kuraoka, I., & Oda, S. (2024). Mutation spectra of the BRCA1 / 2 genes in human breast and ovarian cancer and germline. Environmental and Molecular Mutagenesis. https://doi.org/10.1002/em.22614

Vancouver

Koi Y, Watanabe A, Kawasaki A, Ideo S, Matsutani N, Miyashita K, et al. Mutation spectra of the BRCA1 / 2 genes in human breast and ovarian cancer and germline. Environmental and Molecular Mutagenesis. 2024. doi:10.1002/em.22614

BibTeX
@article{Koi2024,
  author = {Koi, Yumiko and Watanabe, Arisa and Kawasaki, Akari and Ideo, Satomi and Matsutani, Nao and Miyashita, Kaname and Shioi, Seijiro and Tokunaga, Eriko and Shimokawa, Mototsugu and Nakatsu, Yoshimichi and Kuraoka, Isao and Oda, Shinya},
  title = {Mutation spectra of the BRCA1 / 2 genes in human breast and ovarian cancer and germline},
  journal = {Environmental and Molecular Mutagenesis},
  year = {2024},
  doi = {10.1002/em.22614}
}
Kostenlos starten →